| Financial Year |
March 31 2023 |
| Monetary Funds |
2,716,643,731.86 |
| Held-for-trading Financial Assets |
106,134,966.87 |
| Notes Receivable |
175,738,483.79 |
| Accounts Receivable |
1,728,025,691.52 |
| Advances to Suppliers |
272,126,153.17 |
| Other Receivables |
251,955,565.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
1,011,613.19 |
| Dividend Receivable |
84,486,740.73 |
| Inventories |
3,080,408,088.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
3,210,864.18 |
| Other Current Assets |
59,556,791.90 |
| Total Current Assets |
8,547,631,096.39 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,371,320.07 |
| Long-term Equity Investment |
1,562,991,332.46 |
| Investment Properties |
316,678,699.46 |
| Fixed Assetes |
2,164,519,425.07 |
| Under-construction Projects |
518,038,952.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
467,566,148.11 |
| R&D expenses |
-- |
| Goodwill |
268,758,873.76 |
| Long-Term Deferred and Prepaid Expenses |
128,121,834.74 |
| Deferred Income Tax Assets |
84,607,540.25 |
| Other Non-Current Assets |
48,809,289.18 |
| Sub-Total of Non-Current Assets |
5,781,873,341.28 |
| Total Assets |
14,329,504,437.67 |
| Short-Term Loans |
892,901,407.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
498,802,345.76 |
| Accounts Payable |
2,054,293,505.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
184,210,634.59 |
| Taxes Payable |
72,066,442.66 |
| Interest Payable |
-- |
| Dividend Payable |
59,234,875.91 |
| Other payables |
458,541,944.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
72,075,900.74 |
| Other Current Liabilities |
391,517,393.20 |
| Sub-Total of Current Liabilities |
6,760,745,289.00 |
| Long-term Loans |
119,266,409.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
755,074.85 |
| Special Payable |
-- |
| Estimatied Liabilities |
6,400,000.00 |
| Deferred Income Tax Liabilities |
79,269,574.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
288,537,431.17 |
| Total Liabilities |
7,049,282,720.17 |
| Paid-In Capital(Or Share Stock) |
466,874,989.00 |
| Capital Surplus |
2,953,530,567.91 |
| Surplus Reserve |
297,560,668.62 |
| LESS:Treasury Stock |
62,456,968.00 |
| Undistributed Profits |
3,184,117,470.92 |
| Minority Stockholder's Interest |
401,871,526.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,878,350,191.11 |
| Owner's Equity（Stockholder's Equity） |
7,280,221,717.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,329,504,437.67 |
